MEDICINE PROCUREMENT NOTICES:
11 March 2025 - Geneva, Switzerland - On behalf of Stop TB Partnership's Global Drug Facility (GDF), i+solutions, the GDF-contracted procurement agent, invites all eligible suppliers to submit bids for:
ITB-Iplus/GDF-MED/2025/1 for pretomanid 200mg tablets for the period from 1st April 2025 until 30th September 2025.
The purpose of the Invitation To Bid (ITB) is to select a panel of suppliers who will enter into a long-term agreement with i+solutions on behalf of GDF, for the supply of pretomanid 200mg tablets. The ITB is open to bidders whose products have been deemed eligible for inclusion in the tender in compliance with GDF's Quality Assurance policy and procedures (https://www.stoptb.org/suppliers/quality-assurance). A bid submitted for a product/s for which the bidder has not received regulatory approval status in accordance with the GDF Quality Assurance policy and procedures will not be considered for the ITB evaluation.
All bids are subject to the Instructions to Bidders and other provisions, specifications and instructions as contained in this dossier.
The ITB comprises of the following:
Annex A. Financial Bid Response Form (Excel file)
Annex B. List and technical specifications of products requested
Annex C. List of priority countries for TB medicines registration
Annex D. i+solutions model Long-Term Agreement (LTA)
Annex E. Declaration of supply restrictions to countries
Annex F. CDP technical tender submission – instructions for use
Annex G. GDF access to supplier information for WHO PQP and ERP assessed TB medicines
Annex H. Indicative non-binding estimated quantities
Annex J. GDF packaging artwork development guidelines
Annex K. Form for Requests for Clarifications or Complaints after ITB awarding
Annex L. TB medicines target prices
Failure to adhere to the requirements of the ITB may lead to disqualification of the bidder and/or rejection of the bid.
Deadline for the Request for Clarification on the ITB:
12 March 2025, 17h00 IST (India Standard Time) / 12h30 CET (Central European Time)
Deadline for electronic submission of Technical and Financial Bids:
18 March 2025, 17h00 IST (India Standard Time) or 12h30 CET (Central European Time)
Any bids submitted after the deadline will be rejected and not be considered during the evaluation.
Opening of the Financial Bids (remotely):
19 March 2025 at 14h00 IST (India Standard Time) / 9h30 CET (Central European Time)
13 March 2025 - Geneva, Switzerland
Revision of the ITB document for ITB-Iplus/GDF-MED/2025/1
Dear Bidders,
Please note that the ITB document has been revised. The following clauses have been amended:
- Clause 1.4: CDP entry cut-off date
- Clause 3.9.5 of the ITB document
Please refer to the revised ITB document: ITB document Revision 1, dated 13.03.2025
DIAGNOSTICS, MEDICAL DEVICES AND LABORATORY SUPPLIES PROCUREMENT NOTICES:
18 March 2025 - Geneva, Switzerland - Stop TB Partnership - Global Drug Facility (GDF) hosted by the United Nations Office for Project Services (UNOPS) has published Request for Proposal (RFP) for the Establishment of Long-Term Agreement (LTA) with Supplier/s of General Laboratory Supplies and invite all eligible offerors to submit their proposals.
The link to the RFP documents can be found here: https://www.ungm.org/Public/Notice/262058
Reference: RFP/2025/55678
Published on: 17-Mach-2024
28 April 2025 Deadline for the Clarifications and Questions on the RFP
07 May 2025 RFP closing date and time
Any proposal submitted after the deadline will be rejected and not be considered during the evaluation.